There is good news and bad news. Let’s get the bad news out of the way first. Good Days announced that they have no further funding available for 2017 for PAH patients. Now the good news - Caring Voices announced that they will reopen their funding for 2017 beginning Thursday December 8th in the morning. It is unclear how long they will remain open and how many patients … [Read more...]
Copay, Co-Insurance, Deductibles and Out of Pocket Maximum
Understanding the basic terminology of your health insurance is vitally important for patients with Pulmonary Hypertension. As a consumer of health care you need to understand how the system works and the language the insurance company uses to describe their coverage. Deductible A deductible is the amount of money that the patient must pay before their insurance begins to … [Read more...]
Update on Caring Voices for PAH Meds
We received notification today that Caring Voices has closed their 2017 roster of patients that they are able to help for the time being. Very little guidance was given about what this means for the remainder of 2017. There is a possibility that they will reopen their roster and be able to expand the number of PAH patients that they help. Unfortunately this has left … [Read more...]
Medicare: What You Need to Know
With Medicare Open Enrollment currently underway (October 15th through December 7th) we thought this would be a good time to review some basic facts about Medicare. So if you have chronic lung disease like Pulmonary Arterial Hypertension or Pulmonary Fibrosis, here's what you need to know. What is Medicare? Medicare is the federal health insurance program for people 65 and … [Read more...]
How Will I Afford My PAH Medications?
The cost of Pulmonary Arterial Hypertension medications is staggering. The least expensive medication (generic sildenafil) costs $50 per month for 90 tablets. If you prefer to have the branded version and you don’t have any insurance expect to pay more than $3,000 per month. Insurance companies are very happy to pay for generic sildenafil but increasingly restrict Adcirca … [Read more...]
